DVAX
NASDAQ · Biotechnology
Dynavax Technologies Corp
$15.50
+0.00 (+0.00%)
Open$15.49
Previous Close$15.50
Day High$15.50
Day Low$15.49
52W High$15.73
52W Low$9.92
Volume—
Avg Volume2.86M
Market Cap1.76B
P/E Ratio—
EPS$-0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
-10.3% upside
Current
$15.50
$15.50
Target
$13.91
$13.91
$9.87
$13.91 avg
$23.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 236.37M | 275.59M | 289.50M |
| Net Income | 23.28M | 24.43M | -60,500,728 |
| Profit Margin | 9.9% | 9.4% | -20.9% |
| EBITDA | 432.0K | 478.5K | -85,556,315 |
| Free Cash Flow | — | — | -57,246,430 |
| Rev Growth | -14.2% | -14.2% | -5.1% |
| Debt/Equity | 0.38 | 0.38 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |